Identification of a novel perifornical-hypothalamic-area-projecting serotonergic system that inhibits innate panic and conditioned fear responses.
Journal Information
Full Title: Transl Psychiatry
Abbreviation: Transl Psychiatry
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests AS is a founder of biotech companies Anagin Inc., Gate Neurosciences, Monument Bio, and MindX, as well as a scientific advisor and stockholder for Karuna Therapeutics and Aardwolf Therapeutics. CB, IC, AA, AM, WT, and PJ declare no competing interests."
Funding Disclosure
Evidence found in paper:
"This work was supported with K01AG044466 to PJ, R01 MH122843 to PJ and WT, R01 MH106568 to WT, and R01 MH52619 to AS."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025